European Cancer Patient Coalition

European Cancer Patient Coalition
Name	European Cancer Patient Coalition
Abbreviation	ECPC
Formation	2003
Type	Non-governmental organization
Headquarters	Brussels
Region served	Europe
Leader title	President
Leader name	Margareth Sabol (example)

European Cancer Patient Coalition is a pan-European advocacy organization representing patients affected by cancer across European Union member states, candidate countries and associated nations. Founded in Brussels in 2003, the coalition unites national cancer patient groups, disease-specific organizations and individual advocates to influence European Parliament policy, clinical practice in World Health Organization Europe and research agendas in funding bodies such as the European Commission and European Medicines Agency. The coalition engages with stakeholders including professional societies, research networks and industry consortia to promote patient-centered care, equitable access to treatment and survivorship services.

History

The organization was established following consultations between national patient groups, activists linked to the European Commission's cancer initiatives and representatives from the European Cancer Organisation and the Union for International Cancer Control. Early meetings involved advocacy leaders from groups such as Cancer Research UK, Ligue contre le cancer, Deutsche Krebshilfe and survivor networks from Poland, Romania and Spain. In its formative years the coalition participated in dialogues around the European Partnership for Action Against Cancer and contributed to the development of the Europe's Beating Cancer Plan. Over time the coalition expanded membership during key policy moments tied to the Oncology Days and consultations led by the European Patients' Forum.

Mission and Objectives

The coalition's stated mission is to represent the collective voice of cancer patients in policy, research and care delivery across Europe. Core objectives include promoting timely access to novel therapies approved by the European Medicines Agency, championing the implementation of evidence-based European Society for Medical Oncology guidelines, and reducing disparities between regions such as Central Europe and Western Europe. It aims to influence funding priorities at the Horizon Europe research programme level, contribute to standards developed by the Organisation for Economic Co-operation and Development and advocate for survivorship policies aligned with work by the International Agency for Research on Cancer.

Governance and Membership

The coalition is governed by a board of patient representatives and elected officers drawn from member organizations, with oversight mechanisms comparable to those in other pan-European NGOs like the European Patient Forum and European Public Health Alliance. Membership comprises national coalitions, disease-specific charities such as Breast Cancer Now and European Society for Paediatric Oncology-linked groups, as well as individual patient advocates who have participated in panels at the European Parliament or served on advisory boards for the European Commission. The governance model includes working groups covering clinical trials, access to medicines, and digital health, reflecting intersections with institutions like European Institute of Oncology and networks such as the European Reference Networks.

Key Activities and Programs

Activities include organizing conferences and patient summits in partnership with venues in Brussels, launching awareness campaigns timed with World Cancer Day, and producing position papers submitted to consultations by the European Medicines Agency and the European Commission Directorate-Generals. Programs encompass patient involvement frameworks for clinical trials coordinated with groups listed in ClinicalTrials.gov registries, educational modules aligned with curricula from the European School of Oncology, and survivorship initiatives modelled on efforts by the International Psycho-Oncology Society. The coalition runs benchmarking projects comparing access metrics across countries such as France, Germany, Italy and Poland and publishes reports used by think tanks like the European Policy Centre.

Advocacy and Policy Impact

The coalition has influenced legislation and policy papers debated in the European Parliament committees, contributed to revisions of orphan medicinal product pathways administered by the European Medicines Agency, and provided patient input into the Europe's Beating Cancer Plan formulation. It has engaged with policymakers from member states to address reimbursement disparities highlighted in dialogues with bodies such as the European Observatory on Health Systems and Policies and the Council of the European Union. Through advocacy campaigns it has shaped discussions on topics addressed by NGOs like Macmillan Cancer Support and professional bodies including the European Association for Cancer Research.

Partnerships and Collaborations

Strategic partnerships include collaborations with the European Commission's cancer task forces, alliances with scientific organizations like the European Society for Medical Oncology and multi-stakeholder initiatives involving the Pharmaceutical Research and Manufacturers of America and European industry counterparts. The coalition works with patient networks such as the European Patient Forum, research consortia funded by Horizon Europe, and data initiatives connected to the European Health Data Space. It has formal ties with registry projects run by institutions like the International Agency for Research on Cancer and collaborates with regional bodies including the European Centre for Disease Prevention and Control on screening and prevention campaigns.

Funding and Financial Structure

Funding sources combine membership fees from national organizations, grants from supranational programmes including Horizon Europe and project-specific contracts with the European Commission, alongside philanthropic support from foundations such as the Wellcome Trust and corporate sponsorships from pharmaceutical companies operating under codes of conduct set by the European Federation of Pharmaceutical Industries and Associations. Financial oversight follows standards observed by NGOs like the King Baudouin Foundation and reporting practices expected by auditors engaged in EU-funded projects. The coalition publishes summaries of funded projects and annual activity reports used by stakeholders including the European Court of Auditors and partner organisations.

Category:Patient advocacy Category:Cancer organizations